 | • レポートコード：MRC2-11QY12276 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は高コレステロール血症治療のグローバル市場について調査・分析したレポートです。種類別（AEM-2802、AEM-2814、アリロクマブ、エビナクマブ、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別高コレステロール血症治療の競争状況、市場シェア ・世界の高コレステロール血症治療市場：種類別市場規模 2015年-2020年（AEM-2802、AEM-2814、アリロクマブ、エビナクマブ、その他） ・世界の高コレステロール血症治療市場：種類別市場規模予測 2021年-2026年（AEM-2802、AEM-2814、アリロクマブ、エビナクマブ、その他） ・世界の高コレステロール血症治療市場：用途別市場規模 2015年-2020年（クリニック、病院、その他） ・世界の高コレステロール血症治療市場：用途別市場規模予測 2021年-2026年（クリニック、病院、その他） ・北米の高コレステロール血症治療市場分析：米国、カナダ ・ヨーロッパの高コレステロール血症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの高コレステロール血症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の高コレステロール血症治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの高コレステロール血症治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：CymaBay Therapeutics Inc、Daewoong Co Ltd、Gemphire Therapeutics Inc、LipimetiX Development Inc、Regeneron Pharmaceuticals Inc、RegenxBio Inc、The Medicines Company ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Hypercholesterolemia is a genetic disorder characterized by very high levels of cholesterol in the blood. Hypercholesterolemia, also termed as dyslipidemia, is a form of hyperlipidemia and hyperlipoproteinemia in the body. Presence of low-density Lipoprotein Cholesterol (LDL-C) or bad cholesterol in the blood, may lead to cardiovascular diseases. Hypercholesterolemia is caused due to a combination of genetic and environmental factors. Environmental factors include excessive diet intake and obesity. In case of genetic factors, the number of copies of the gene determines the severity of the disease. People with the homozygous form (two copies of the gene) generally suffer from severe cardiovascular diseases during childhood, while those with the heterozygous form (with a single copy of the gene) suffer from heart diseases in their 30s or 40s.
Market Analysis and Insights: Global Hypercholesterolemia Treatment Market
The global Hypercholesterolemia Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Hypercholesterolemia Treatment Scope and Market Size
Hypercholesterolemia Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hypercholesterolemia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
CymaBay Therapeutics Inc
Daewoong Co Ltd
Gemphire Therapeutics Inc
LipimetiX Development Inc
Regeneron Pharmaceuticals Inc
RegenxBio Inc
The Medicines Company
…
Market segment by Type, the product can be split into
AEM-2802
AEM-2814
Alirocumab
Evinacumab
Others
Market segment by Application, split into
Clinic
Hospital
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hypercholesterolemia Treatment Revenue
1.4 Market by Type
1.4.1 Global Hypercholesterolemia Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 AEM-2802
1.4.3 AEM-2814
1.4.4 Alirocumab
1.4.5 Evinacumab
1.4.6 Others
1.5 Market by Application
1.5.1 Global Hypercholesterolemia Treatment Market Share by Application: 2020 VS 2026
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Hypercholesterolemia Treatment Market Perspective (2015-2026)
2.2 Global Hypercholesterolemia Treatment Growth Trends by Regions
2.2.1 Hypercholesterolemia Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hypercholesterolemia Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Hypercholesterolemia Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hypercholesterolemia Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Hypercholesterolemia Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Hypercholesterolemia Treatment Players by Market Size
3.1.1 Global Top Hypercholesterolemia Treatment Players by Revenue (2015-2020)
3.1.2 Global Hypercholesterolemia Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Hypercholesterolemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hypercholesterolemia Treatment Market Concentration Ratio
3.2.1 Global Hypercholesterolemia Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hypercholesterolemia Treatment Revenue in 2019
3.3 Hypercholesterolemia Treatment Key Players Head office and Area Served
3.4 Key Players Hypercholesterolemia Treatment Product Solution and Service
3.5 Date of Enter into Hypercholesterolemia Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hypercholesterolemia Treatment Historic Market Size by Type (2015-2020)
4.2 Global Hypercholesterolemia Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Hypercholesterolemia Treatment Market Size by Application (2015-2020)
5.2 Global Hypercholesterolemia Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Hypercholesterolemia Treatment Market Size (2015-2020)
6.2 Hypercholesterolemia Treatment Key Players in North America (2019-2020)
6.3 North America Hypercholesterolemia Treatment Market Size by Type (2015-2020)
6.4 North America Hypercholesterolemia Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Hypercholesterolemia Treatment Market Size (2015-2020)
7.2 Hypercholesterolemia Treatment Key Players in Europe (2019-2020)
7.3 Europe Hypercholesterolemia Treatment Market Size by Type (2015-2020)
7.4 Europe Hypercholesterolemia Treatment Market Size by Application (2015-2020)
8 China
8.1 China Hypercholesterolemia Treatment Market Size (2015-2020)
8.2 Hypercholesterolemia Treatment Key Players in China (2019-2020)
8.3 China Hypercholesterolemia Treatment Market Size by Type (2015-2020)
8.4 China Hypercholesterolemia Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Hypercholesterolemia Treatment Market Size (2015-2020)
9.2 Hypercholesterolemia Treatment Key Players in Japan (2019-2020)
9.3 Japan Hypercholesterolemia Treatment Market Size by Type (2015-2020)
9.4 Japan Hypercholesterolemia Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Hypercholesterolemia Treatment Market Size (2015-2020)
10.2 Hypercholesterolemia Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hypercholesterolemia Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Hypercholesterolemia Treatment Market Size by Application (2015-2020)
11 India
11.1 India Hypercholesterolemia Treatment Market Size (2015-2020)
11.2 Hypercholesterolemia Treatment Key Players in India (2019-2020)
11.3 India Hypercholesterolemia Treatment Market Size by Type (2015-2020)
11.4 India Hypercholesterolemia Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Hypercholesterolemia Treatment Market Size (2015-2020)
12.2 Hypercholesterolemia Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Hypercholesterolemia Treatment Market Size by Type (2015-2020)
12.4 Central & South America Hypercholesterolemia Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 CymaBay Therapeutics Inc
13.1.1 CymaBay Therapeutics Inc Company Details
13.1.2 CymaBay Therapeutics Inc Business Overview
13.1.3 CymaBay Therapeutics Inc Hypercholesterolemia Treatment Introduction
13.1.4 CymaBay Therapeutics Inc Revenue in Hypercholesterolemia Treatment Business (2015-2020))
13.1.5 CymaBay Therapeutics Inc Recent Development
13.2 Daewoong Co Ltd
13.2.1 Daewoong Co Ltd Company Details
13.2.2 Daewoong Co Ltd Business Overview
13.2.3 Daewoong Co Ltd Hypercholesterolemia Treatment Introduction
13.2.4 Daewoong Co Ltd Revenue in Hypercholesterolemia Treatment Business (2015-2020)
13.2.5 Daewoong Co Ltd Recent Development
13.3 Gemphire Therapeutics Inc
13.3.1 Gemphire Therapeutics Inc Company Details
13.3.2 Gemphire Therapeutics Inc Business Overview
13.3.3 Gemphire Therapeutics Inc Hypercholesterolemia Treatment Introduction
13.3.4 Gemphire Therapeutics Inc Revenue in Hypercholesterolemia Treatment Business (2015-2020)
13.3.5 Gemphire Therapeutics Inc Recent Development
13.4 LipimetiX Development Inc
13.4.1 LipimetiX Development Inc Company Details
13.4.2 LipimetiX Development Inc Business Overview
13.4.3 LipimetiX Development Inc Hypercholesterolemia Treatment Introduction
13.4.4 LipimetiX Development Inc Revenue in Hypercholesterolemia Treatment Business (2015-2020)
13.4.5 LipimetiX Development Inc Recent Development
13.5 Regeneron Pharmaceuticals Inc
13.5.1 Regeneron Pharmaceuticals Inc Company Details
13.5.2 Regeneron Pharmaceuticals Inc Business Overview
13.5.3 Regeneron Pharmaceuticals Inc Hypercholesterolemia Treatment Introduction
13.5.4 Regeneron Pharmaceuticals Inc Revenue in Hypercholesterolemia Treatment Business (2015-2020)
13.5.5 Regeneron Pharmaceuticals Inc Recent Development
13.6 RegenxBio Inc
13.6.1 RegenxBio Inc Company Details
13.6.2 RegenxBio Inc Business Overview
13.6.3 RegenxBio Inc Hypercholesterolemia Treatment Introduction
13.6.4 RegenxBio Inc Revenue in Hypercholesterolemia Treatment Business (2015-2020)
13.6.5 RegenxBio Inc Recent Development
13.7 The Medicines Company
13.7.1 The Medicines Company Company Details
13.7.2 The Medicines Company Business Overview
13.7.3 The Medicines Company Hypercholesterolemia Treatment Introduction
13.7.4 The Medicines Company Revenue in Hypercholesterolemia Treatment Business (2015-2020)
13.7.5 The Medicines Company Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Hypercholesterolemia Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Hypercholesterolemia Treatment Revenue
Table 3. Ranking of Global Top Hypercholesterolemia Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hypercholesterolemia Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of AEM-2802
Table 6. Key Players of AEM-2814
Table 7. Key Players of Alirocumab
Table 8. Key Players of Evinacumab
Table 9. Key Players of Others
Table 10. Global Hypercholesterolemia Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Hypercholesterolemia Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Hypercholesterolemia Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Hypercholesterolemia Treatment Market Share by Regions (2015-2020)
Table 14. Global Hypercholesterolemia Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Hypercholesterolemia Treatment Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Hypercholesterolemia Treatment Market Growth Strategy
Table 20. Main Points Interviewed from Key Hypercholesterolemia Treatment Players
Table 21. Global Hypercholesterolemia Treatment Revenue by Players (2015-2020) (Million US$)
Table 22. Global Hypercholesterolemia Treatment Market Share by Players (2015-2020)
Table 23. Global Top Hypercholesterolemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypercholesterolemia Treatment as of 2019)
Table 24. Global Hypercholesterolemia Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Hypercholesterolemia Treatment Product Solution and Service
Table 27. Date of Enter into Hypercholesterolemia Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Hypercholesterolemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 30. Global Hypercholesterolemia Treatment Market Size Share by Type (2015-2020)
Table 31. Global Hypercholesterolemia Treatment Revenue Market Share by Type (2021-2026)
Table 32. Global Hypercholesterolemia Treatment Market Size Share by Application (2015-2020)
Table 33. Global Hypercholesterolemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 34. Global Hypercholesterolemia Treatment Market Size Share by Application (2021-2026)
Table 35. North America Key Players Hypercholesterolemia Treatment Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Hypercholesterolemia Treatment Market Share (2019-2020)
Table 37. North America Hypercholesterolemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 38. North America Hypercholesterolemia Treatment Market Share by Type (2015-2020)
Table 39. North America Hypercholesterolemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 40. North America Hypercholesterolemia Treatment Market Share by Application (2015-2020)
Table 41. Europe Key Players Hypercholesterolemia Treatment Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Hypercholesterolemia Treatment Market Share (2019-2020)
Table 43. Europe Hypercholesterolemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Hypercholesterolemia Treatment Market Share by Type (2015-2020)
Table 45. Europe Hypercholesterolemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Hypercholesterolemia Treatment Market Share by Application (2015-2020)
Table 47. China Key Players Hypercholesterolemia Treatment Revenue (2019-2020) (Million US$)
Table 48. China Key Players Hypercholesterolemia Treatment Market Share (2019-2020)
Table 49. China Hypercholesterolemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 50. China Hypercholesterolemia Treatment Market Share by Type (2015-2020)
Table 51. China Hypercholesterolemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 52. China Hypercholesterolemia Treatment Market Share by Application (2015-2020)
Table 53. Japan Key Players Hypercholesterolemia Treatment Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Hypercholesterolemia Treatment Market Share (2019-2020)
Table 55. Japan Hypercholesterolemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Hypercholesterolemia Treatment Market Share by Type (2015-2020)
Table 57. Japan Hypercholesterolemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Hypercholesterolemia Treatment Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Hypercholesterolemia Treatment Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Hypercholesterolemia Treatment Market Share (2019-2020)
Table 61. Southeast Asia Hypercholesterolemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Hypercholesterolemia Treatment Market Share by Type (2015-2020)
Table 63. Southeast Asia Hypercholesterolemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Hypercholesterolemia Treatment Market Share by Application (2015-2020)
Table 65. India Key Players Hypercholesterolemia Treatment Revenue (2019-2020) (Million US$)
Table 66. India Key Players Hypercholesterolemia Treatment Market Share (2019-2020)
Table 67. India Hypercholesterolemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 68. India Hypercholesterolemia Treatment Market Share by Type (2015-2020)
Table 69. India Hypercholesterolemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 70. India Hypercholesterolemia Treatment Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Hypercholesterolemia Treatment Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Hypercholesterolemia Treatment Market Share (2019-2020)
Table 73. Central & South America Hypercholesterolemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Hypercholesterolemia Treatment Market Share by Type (2015-2020)
Table 75. Central & South America Hypercholesterolemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Hypercholesterolemia Treatment Market Share by Application (2015-2020)
Table 77. CymaBay Therapeutics Inc Company Details
Table 78. CymaBay Therapeutics Inc Business Overview
Table 79. CymaBay Therapeutics Inc Product
Table 80. CymaBay Therapeutics Inc Revenue in Hypercholesterolemia Treatment Business (2015-2020) (Million US$)
Table 81. CymaBay Therapeutics Inc Recent Development
Table 82. Daewoong Co Ltd Company Details
Table 83. Daewoong Co Ltd Business Overview
Table 84. Daewoong Co Ltd Product
Table 85. Daewoong Co Ltd Revenue in Hypercholesterolemia Treatment Business (2015-2020) (Million US$)
Table 86. Daewoong Co Ltd Recent Development
Table 87. Gemphire Therapeutics Inc Company Details
Table 88. Gemphire Therapeutics Inc Business Overview
Table 89. Gemphire Therapeutics Inc Product
Table 90. Gemphire Therapeutics Inc Revenue in Hypercholesterolemia Treatment Business (2015-2020) (Million US$)
Table 91. Gemphire Therapeutics Inc Recent Development
Table 92. LipimetiX Development Inc Company Details
Table 93. LipimetiX Development Inc Business Overview
Table 94. LipimetiX Development Inc Product
Table 95. LipimetiX Development Inc Revenue in Hypercholesterolemia Treatment Business (2015-2020) (Million US$)
Table 96. LipimetiX Development Inc Recent Development
Table 97. Regeneron Pharmaceuticals Inc Company Details
Table 98. Regeneron Pharmaceuticals Inc Business Overview
Table 99. Regeneron Pharmaceuticals Inc Product
Table 100. Regeneron Pharmaceuticals Inc Revenue in Hypercholesterolemia Treatment Business (2015-2020) (Million US$)
Table 101. Regeneron Pharmaceuticals Inc Recent Development
Table 102. RegenxBio Inc Company Details
Table 103. RegenxBio Inc Business Overview
Table 104. RegenxBio Inc Product
Table 105. RegenxBio Inc Revenue in Hypercholesterolemia Treatment Business (2015-2020) (Million US$)
Table 106. RegenxBio Inc Recent Development
Table 107. The Medicines Company Company Details
Table 108. The Medicines Company Business Overview
Table 109. The Medicines Company Product
Table 110. The Medicines Company Revenue in Hypercholesterolemia Treatment Business (2015-2020) (Million US$)
Table 111. The Medicines Company Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hypercholesterolemia Treatment Market Share by Type: 2020 VS 2026
Figure 2. AEM-2802 Features
Figure 3. AEM-2814 Features
Figure 4. Alirocumab Features
Figure 5. Evinacumab Features
Figure 6. Others Features
Figure 7. Global Hypercholesterolemia Treatment Market Share by Application: 2020 VS 2026
Figure 8. Clinic Case Studies
Figure 9. Hospital Case Studies
Figure 10. Others Case Studies
Figure 11. Hypercholesterolemia Treatment Report Years Considered
Figure 12. Global Hypercholesterolemia Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Hypercholesterolemia Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Hypercholesterolemia Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Hypercholesterolemia Treatment Market Share by Players in 2019
Figure 17. Global Top Hypercholesterolemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypercholesterolemia Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Hypercholesterolemia Treatment Revenue in 2019
Figure 19. North America Hypercholesterolemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Hypercholesterolemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Hypercholesterolemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Hypercholesterolemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Hypercholesterolemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Hypercholesterolemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Hypercholesterolemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
ホモ接合性家族性高コレステロール血症治療の世界市場（～2026年） Market Analysis and Insights: Global Homozygous Familial Hypercholesterolemia Treatment Market The global Homozygous Familial Hypercholesterolemia Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Homozygous Fa…- ヘテロ接合性家族性高コレステロール血症薬の世界市場（～2026年） Market Analysis and Insights: Global Heterozygous Familial Hypercholesterolemia Drug Market The global Heterozygous Familial Hypercholesterolemia Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Heterozygous Famili…
- 高コレステロール血症薬の世界市場（～2026年） Hypercholesterolemia also known as high cholesterol, is the presence of excess levels of cholesterol in the body that increases a risk of developing heart attack, and stroke. Changes in lifestyle pattern such as the adoption of a sedentary form, increasing rate alcohol consumption and change in diet…
- 統合失調感情障害治療の世界市場（～2026年） Types of schizoaffective disorders include manic, depressive, mixed, and schizoaffective disorders. The regional market for schizoaffective affective disorders is very common in North America, Europe and Asia Pacific. Market Analysis and Insights: Global Schizoaffective Disorders Treatment Market Th…
- 巨細胞性動脈炎治療の世界市場（～2026年） Giant cell arteritis is also known as temporal arteritis, is a type of disease which causes inflammation of medium and large vessels that occurs only in individuals older than 50 years of age. Seasonal variations in the incidence of giant cell arteritis treatment suggest a possible infective origin …